Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
08/08/1996 | WO1996023812A1 Proline derivatives useful as inhibitors of human leukocyte elastase |
08/08/1996 | WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
08/08/1996 | WO1996023785A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists |
08/08/1996 | WO1996023523A1 Novel hemostatic composition |
08/08/1996 | WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof |
08/08/1996 | CA2211189A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists |
08/08/1996 | CA2209675A1 Proline derivatives useful as inhibitors of human leukocyte elastase |
08/07/1996 | EP0725075A1 Peptide derivatives comprising a phosphinic acid moiety as inhibitors of zinc depending endopeptidase 24-25 |
08/07/1996 | EP0725064A1 Use of phenylcyclohexylcarboxylic amides |
08/07/1996 | EP0725062A1 4-mercapto-benzoylguanidine derivatives |
08/07/1996 | EP0725061A1 Substituted indole derivatives |
08/07/1996 | EP0724877A1 Mixture of fenofibrate and vitamin E and its therapeutic use |
08/07/1996 | EP0724647A1 Nucleic acid ligands and improved methods for producing the same |
08/07/1996 | EP0724637A1 Corticotropin-releasing factor 2 receptors |
08/07/1996 | EP0724599A1 Platelet-derived growth factor analogues |
08/07/1996 | EP0724584A1 Heterocyclic amines having central nervous system activity |
08/07/1996 | EP0724583A1 Pyridazino quinoline compounds |
08/07/1996 | EP0724578A1 Amine derivatives as calcium channel antagonists |
08/07/1996 | EP0724577A1 Heterocyclic amines for treating ischaemic strokes |
08/07/1996 | EP0724570A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
08/07/1996 | EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
08/07/1996 | EP0724561A1 Calcium receptor-active arylalkyl amines |
08/07/1996 | EP0724439A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents |
08/07/1996 | EP0724435A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
08/07/1996 | EP0661981B1 Use of hyaluronic acid and forms to prevent arterial restenosis |
08/07/1996 | EP0576617B1 Composition and method containing optically pure (s) metoprolol |
08/07/1996 | CN1128536A Benzopyrans and pharmaceutical compositions containing them |
08/07/1996 | CN1128262A Substituted biphenyl isoxazole sulfonamides |
08/07/1996 | CN1128261A Process for the preparation of a tetrazole derivative in two crystalline forms and novel crystalline form of said derivative |
08/06/1996 | US5543542 Reacting phosphonosulfonate with oxidizing agent, reacting product with hydroxylamine protecting agent, then with silyl bromide or iodide |
08/06/1996 | US5543528 Useful as angiotensin ii antagonist |
08/06/1996 | US5543430 Method and formulation of stimulating nitric oxide synthesis |
08/06/1996 | US5543421 Method of treatment of peripheral neuropathies and central neurodegenerative diseases |
08/06/1996 | US5543411 Hydroxylated metabolites and derivatives of doxazosin as anti-atherosclerosis agents |
08/06/1996 | US5543138 Methods of diagnosing and treating preeclampsia |
08/02/1996 | CA2168513A1 Preventive or alleviative agent for hypertension or medical symptoms caused thereby |
08/02/1996 | CA2168320A1 Substituted indole derivatives |
08/02/1996 | CA2168317A1 Use of phenylcyclohexylcarboxamides |
08/01/1996 | WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
08/01/1996 | WO1996023065A2 Inhibition of neovascularization using vegf-specific oligonucleotides |
08/01/1996 | WO1996022998A1 Thiol derivatives with metallopeptidase inhibitory activity |
08/01/1996 | WO1996022978A1 Substituted phenyl compounds as endothelin antagonists |
08/01/1996 | WO1996022976A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
08/01/1996 | CA2210151A1 Thiol derivatives with metallopeptidase inhibitory activity |
07/31/1996 | EP0723974A1 Derivatives of mercaptoalkanoyldipeptides, their preparation and pharmaceutical compositions containing them |
07/31/1996 | EP0723969A1 Phosphonocarboxylic acid derivatives and their use in treating degenerative articular ailments |
07/31/1996 | EP0723963A1 4-amino-benzoylguanidine derivatives |
07/31/1996 | EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them |
07/31/1996 | EP0723956A1 Basically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics as well as medicaments containing them |
07/31/1996 | EP0723552A1 Oligopeptides derived from c-reactive protein fragments |
07/31/1996 | EP0723537A1 Benzothiophenes and related compounds as estrogen agonists |
07/31/1996 | EP0723449A1 Endothelin receptor antagonists |
07/31/1996 | EP0723447A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
07/31/1996 | EP0723445A1 Analgesic agent and its use |
07/31/1996 | EP0723439A1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
07/31/1996 | EP0723438A1 Substituted urea and isothiourea derivatives as no synthase inhibitors |
07/31/1996 | EP0723434A1 New beads for controlled release and a pharmaceutical preparation containing the same |
07/31/1996 | EP0557319B1 Therapeutic use of fibroblast growth factor |
07/31/1996 | EP0471754B1 Production of vascular endothelial cell growth factor and dna encoding same |
07/31/1996 | CN1128030A Heterocyclic amines having central nervous system activity |
07/31/1996 | CN1128028A N-morpholino-N-nitrosaminoacetonitril cyclodextrin inclusion complexes |
07/31/1996 | CN1128025A Benzoxazinones and benzothiazinones endowed with therapeutic activity |
07/31/1996 | CN1128022A Nipecotic acid derivatives as antithrombic compounds |
07/31/1996 | CN1127991A Method to inhibit restenosis |
07/31/1996 | CN1127757A New tetrahydropyran compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
07/31/1996 | CN1127752A Method of manufacturing the cycloheptimidazole derivatives |
07/31/1996 | CN1127749A Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
07/31/1996 | CA2168315A1 Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them |
07/30/1996 | US5541343 Cyclic imino derivatives and pharmaceutical compositions containing them |
07/30/1996 | US5541319 Reacting substituted benzazepine ether with boron trihalide to form hydroxy group, forming salt with base if desired |
07/30/1996 | US5541229 Benzimidazoles and medicaments containing these compounds |
07/30/1996 | US5541198 Antisticking agents for platelets |
07/30/1996 | US5541183 Ginkgolide derivatives |
07/30/1996 | US5541180 Headache therapy |
07/30/1996 | US5541163 Renin inhibiting N-(2-amino-2-oxoethyl)butanediamide derivatives |
07/30/1996 | US5541111 Lactobacillus helveticus mutants having low increase in acidity of lactic acid during storage |
07/26/1996 | CA2167979A1 Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders |
07/25/1996 | WO1996022306A1 Novel peptide |
07/25/1996 | WO1996022295A1 Tricyclic benzazepine vasopressin antagonists |
07/25/1996 | WO1996022294A1 Bicyclic benzazepine derivatives as vasopressin antagonists |
07/25/1996 | WO1996022293A1 Tricyclic benzazepine vasopressin antagonists |
07/25/1996 | WO1996022290A1 Compounds having effects on serotonin-related systems |
07/25/1996 | WO1996022288A1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
07/25/1996 | WO1996022279A1 New derivatives of glycylanilides, preparation and therapeutical application |
07/25/1996 | WO1996022104A1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
07/25/1996 | WO1996008228A3 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
07/25/1996 | CA2211342A1 New derivatives of glycylanilides, preparation and therapeutical application |
07/25/1996 | CA2210682A1 Glycoprotein iib/iiia antagonists |
07/25/1996 | CA2210632A1 Tricyclic benzazepine vasopressin antagonists |
07/25/1996 | CA2210571A1 Bicyclic benzazepine derivatives as vasopressin antagonists |
07/25/1996 | CA2210220A1 Compounds having effects on serotonin-related systems |
07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
07/24/1996 | EP0722944A1 2-9-Disubstituted Purin-6-ones |
07/24/1996 | EP0722943A1 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
07/24/1996 | EP0722941A2 Compounds having effects on serotonin-related systems |
07/24/1996 | EP0722937A1 2,8-Disubstituted quinazolinone |
07/24/1996 | EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof |
07/24/1996 | EP0722735A1 Parathyroid hypertensive factor |
07/24/1996 | EP0722460A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
07/24/1996 | EP0722438A1 Hydroxamic acid derivatives as inhibitors of cytokine production |